Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent
1986-10-02
1989-02-28
Berch, Mark L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
514887, C07D 3158
Patent
active
048086100
ABSTRACT:
Disclosed is an elegant, stable, self-preserving cream formulation containing mometasone furoate, 9.alpha., 21-dichloro-16.alpha.-methyl-1,4-pregnadiene-11.beta.,17.alpha.-diol-3,20- dione-17-(2'-furoate), useful as a topical anti-inflammatory product.
REFERENCES:
patent: 4070462 (1978-01-01), Ecker
patent: 4124707 (1978-11-01), Green et al.
patent: 4201778 (1980-05-01), Draper
patent: 4267173 (1981-05-01), Draper
patent: 4472393 (1984-09-01), Shapiro
Munayyer Farah J.
Sequeira Joel A.
Berch Mark L.
Maitner John J.
Miller Stephen I.
Rosen Gerald S.
Schering Corporation
LandOfFree
Mometasone furoate anti-inflammatory cream composition using hex does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Mometasone furoate anti-inflammatory cream composition using hex, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mometasone furoate anti-inflammatory cream composition using hex will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1367473